Abstract
Objective: To outline specific challenges facing public health in Canada that need to be addressed to ensure that all women of childbearing years can attain optimal folate status for prevention of NTDs.
Methods: The new Dietary Reference Intake (DRI) for folate was examined in terms of the literature on the effective form of the vitamin, the level of folic acid provided by the Canadian food supply and the folic acid content of available supplements.
Findings: There are six major challenges facing public health in Canada on this issue. These include confusion among health professionals and the general public on the effective form of the vitamin, requirements, and the necessity of taking supplements. Further obstacles to ensuring optimal folate status in all women of childbearing age in Canada include the limited amounts of folic acid that are currently permitted in foods and the difficulties involved in identifying the amount of folic acid provided in these foods in relation to needs.
Interpretation: These challenges must be addressed to enable women in Canada to make an informed choice about folic acid. This has the potential to prevent up to 70% of the 300 births affected by NTDs each year.
Résumé
Objectif: Décrire les défis particuliers que doit relever la santé publique au Canada pour que toutes les femmes en âge de procréer aient un niveau de folate optimal pour la prévention des anomalies du tube neural (ATN).
Méthode: Nous avons examiné le nouvel Apport nutritionnel de référence (ANREF) pour le folate à la lumière de la documentation sur les formes efficaces de la vitamine, du niveau d’acide folique dans l’alimentation canadienne et du contenu en acide folique des suppléments nutritifs disponibles.
Constatations: Les responsables de la santé publique au Canada ont six grands défis à relever dans ce dossier, notamment la confusion, parmi les professionnels de la santé et dans le grand public, sur la forme la plus efficace de cette vitamine, sur les besoins en folate et sur la nécessité ou non de prendre des suppléments. Les autres obstacles à surmonter sont les faibles quantités d’acide folique actuellement autorisées dans les aliments et la difficulté de déterminer la quantité d’acide folique dans l’alimentation par rapport aux besoins.
Interprétation: Il faut se pencher sur ces questions pour permettre aux Canadiennes de faire un choix éclairé au sujet de l’acide folique. On pourrait éventuellement prévenir jusqu’à 70 % des ATN, qui touchent 300 naissances chaque année.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
International Centre of Birth Defects. International clearinghouse for birth defects monitoring systems: Annual report, 1998. Rome, Italy.
Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurent neural tube defects. JAMA 1993;269:1257–61.
Czeizel AE, Duda I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832–35.
Wald NJ, Law M, Jordan R. Folic acid food fortification to prevent NTDs. Lancet 1998;351:834–35.
Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and NTDs — Implications for prevention. JAMA 1995;274:1698–702.
Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes: Folate, Other B Vitamins, and Choline. Washington, DC: National Academy Press, April 7, 1998.
Cuskelly GJ, McNulty H, Scott, JM. Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects. Lancet 1996;347:657–59.
Cuskelly GJ, McNulty H, Scott, JM. Fortification with low amounts of folic acid makes a significant difference in folate status in young women: Implications for the prevention of neural tube defects. Am J Clin Nutr 1999;70:234–39.
McNulty H, Cuskelly GJ, Ward M. Responses of red blood cell folate to intervention: Implications for folate recommendations for the prevention of neural tube defects. Am J Clin Nutr 2000;71(suppl):1308S–11S.
Gray-Donald K, Jacobs-Starkey L, Johnson-Down L. Food habits of Canadians: Reduction in fat intake over a generation. Can J Public Health 2000;91(5):381–85.
MRC Vitamin Study Research Group. Prevention of NTDs: Results of the Medical Research Council vitamin study. Lancet 1991;338:131–37.
Gregory, JF. Bioavailability of Nutrients and Other Bioactive Components from Dietary Supplements: Case Study: Folate Bioavailability? J Nutr 2001;131:1376S–82S.
Sauberlich HE, Ketsch MJ, Skala JH, Johnson HL, Taylor, PC. Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 1987;46:1016–28.
Canadian Food and Drug Administration (FDA) Regulations, Health Canada, 1998.
DHHS (U.S. Department of Health and Human Services). Food and Drug Administration. Food Standards: Amendment of the standards of identity for enriched grain products to require addition of folic acid. Fed Regist 61:8781–807.
Laurence KM, James N, Miller M, Campbell H. Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling. Br Med J 1980;281:1592–94.
Wasserman CR, Shaw GM, Selvin S, Gould JB, Syme, SL. Socioeconomic status, neighborhood social conditions and neural tube defects. Am J Public Health 1998;88:1674–80.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reisch, H.S., Flynn, M.A.T. Folic Acid and the Prevention of Neural Tube Defects (NTDs). Can J Public Health 93, 254–258 (2002). https://doi.org/10.1007/BF03405011
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03405011